Ontology highlight
ABSTRACT:
SUBMITTER: O'Donnell MR
PROVIDER: S-EPMC7155388 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
O'Donnell Max R MR Padayatchi Nesri N Daftary Amrita A Orrell Catherine C Dooley Kelly E KE Rivet Amico K K Friedland Gerald G
The lancet. HIV 20190301 3
Bedaquiline, a potent new therapy for drug-resistant tuberculosis, results in improved survival including in HIV patients with multidrug and extensively drug-resistant tuberculosis. In line with WHO recommendations, in South Africa and other low-income and middle-income settings, antiretroviral therapy is switched from generic fixed-dose combination efavirenz-containing regimens to twice-daily nevirapine with separate companion pills because of interactions between efavirenz and bedaquiline. Ear ...[more]